DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Paramount Communications Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 1 hr ago·8 Oct 2026, 9:40 am

Paramount Communications

Paramount Communications Limited has submitted a certificate to the stock exchange, confirming its compliance with the SEBI (Depositories and Participants) Regulations, 2018. This regulatory filing is a standard administrative requirement for listed companies to demonstrate their adherence to the rules governing securities depositories and market intermediaries.

For investors, this development is largely procedural and does not indicate any financial distress or operational issues. It serves as a formal confirmation that the company is maintaining proper records and adhering to the regulatory framework set by the market regulator.

Investors should monitor the exchange filing for any additional details. As this is a routine compliance matter, it is unlikely to impact the stock's price in the short term, but it is always prudent to stay updated on all regulatory disclosures from the company.